Table 2. Matched and adjusted HRs of the investigated diagnoses (E11-J32).
| Per 10 000 person years | Events | Incidence rate (95% CI) per 10 000 person years | Matched HR (95% CI) | Adjusted HR (95% CI) | |
| Diabetes mellitus (E11–14) | |||||
| No asthma | 36.68 | 77 | 2.10 (1.66 to 2.62) | 1 | 1 |
| Asthma | 20.47 | 77 | 3.76 (2.97 to 4.70) | 1.62 (1.13 to2.34) | 2.40(1.45 to3.95) * |
| Transient cerebral events (G45) | |||||
| No asthma | 36.37 | 118 | 3.24 (2.69 to 3.89) | 1 | 1 |
| Asthma | 20.42 | 77 | 3.77 (2.98 to 4.71) | 1.30 (0.92 to 1.84) | 1.35 (0.93 to 1.96) † |
| Sleep apnoea (G47.3) | |||||
| No asthma | 34.20 | 67 | 1.96 (1.52 to 2.49) | 1 | 1 |
| Asthma | 18.85 | 79 | 4.19 (3.32 to 5.22) | 2.21 (1.53 to3.22) | 2.07 (1.32 to3.23) * |
| Senile cataract (H25) | |||||
| No asthma | 34.89 | 406 | 11.64 (10.53 to 12.83) | 1 | 1 |
| Asthma | 19.17 | 319 | 16.64 (14.87 to 18.57) | 1.69 (1.39 to2.04) | 1.65 (1.35 to 2.03) † |
| Hearing loss (H90) | |||||
| No asthma | 35.90 | 189 | 5.27 (4.54 to 6.07) | 1 | 1 |
| Asthma | 20.08 | 129 | 6.43 (5.35 to 7.64) | 1.26 (0.96 to 1.64) | 1.38 (1.01 to 1.88) * |
| Hypertensive diseases (I10) | |||||
| No asthma | 36.03 | 168 | 4.66 (3.98 to 5.42) | 1 | 1 |
| Asthma | 20.38 | 90 | 4.42 (3.55 to 5.43) | 1.10 (0.82 to 1.48) | 1.18 (0.86 to 1.62) † |
| Ischaemic heart diseases (I20, I21, I25) | |||||
| No asthma | 34.43 | 359 | 10.43 (9.38 to 11.56) | 1 | 1 |
| Asthma | 19.19 | 240 | 12.50 (10.97 to 14.19) | 1.35 (1.11 to1.64) | 1.28 (1.02 to 1.61) * |
| Atrial fibrillation and flutter (I48), heart failure (I50) | |||||
| No asthma | 35.59 | 268 | 7.53 (6.66 to 8.49) | 1 | 1 |
| Asthma | 19.94 | 198 | 9.93 (8.60 to 11.41) | 1.43 (1.14 to1.79) | 1.35 (1.05 to 1.75) * |
| Cerebral infarction (I63) | |||||
| No asthma | 36.31 | 134 | 3.69 (3.09 to 4.37) | 1 | 1 |
| Asthma | 20.40 | 110 | 5.39 (4.43 to 6.50) | 1.64 (1.20 to2.23) | 1.65 (1.15 to 2.35) * |
| Varicose veins of lower extremities (I83) | |||||
| No asthma | 36.00 | 107 | 2.97 (2.44 to 3.59) | 1 | 1 |
| Asthma | 20.16 | 79 | 3.92 (3.10 to 4.88) | 1.44(1.04to2.01) | 1.43 (1.01 to 2.03)† |
| Acute rhinosinusitis (J01) | |||||
| No asthma | 36.97 | 17 | 0.46 (0.27 to 0.74) | 1 | 1 |
| Asthma | 20.36 | 54 | 2.65 (1.99 to 3.46) | 4.02 (2.26 to7.17) | 4.26 (2.30 to 8.33) † |
| Pneumonia (J15, J18) | |||||
| No asthma | 36.12 | 230 | 6.37 (5.57 to 7.25) | 1 | 1 |
| Asthma | 19.60 | 255 | 13.00 (11.46 to 14.71) | 2.52 (2.00 to3.17) | 2.29 (1.79 to 2.93) † |
| Allergic rhinitis (J30) | |||||
| No asthma | 36.96 | 18 | 0.49 (0.29 to 0.77) | 1 | 1 |
| Asthma | 20.76 | 22 | 1.06 (0.66 to 1.60) | 1.61 (0.82 to 3.15) | 2.27 (1.18 to 4.35) * |
| Chronic rhinosinusitis (J32) | |||||
| No asthma | 36.58 | 55 | 1.50 (1.13 to 1.96) | 1 | 1 |
| Asthma | 20.49 | 53 | 2.59 (1.94 to 3.38) | 1.83 (1.20 to2.81) | 1.82 (1.15 to 2.87) † |
Adjusted Cox’s multivariate proportional hazards models.
*
Matched for gender, age and area of residence and adjusted for pack- years and body mass index.
†
Matched for gender, age and area of residence and adjusted for pack- years.